Cosma Spolka Akcyjna Logo

Cosma Spolka Akcyjna

Produces natural hemp supplements and pharmaceutical raw materials for retail & wholesale markets.

COS | WAR

Overview

Corporate Details

ISIN(s):
PLVBN0000015 (+5 more)
LEI:
259400QHISD311JE0I22
Country:
Poland
Address:
WARSZAWA WOŁOSKA 22A, 02-675 WARSZAWA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Cosma S.A. is a company specializing in the development, production, and distribution of hemp-based products. The company's portfolio includes natural dietary supplements, such as its innovative Cosma Cannabis line of dual-phase capsules that combine phytocannabinoids with herbs, vitamins, and minerals. Cosma S.A. also develops and registers pharmaceutical raw materials, operating a wholesale business within the pharmaceutical sector. The company utilizes an integrated production chain to ensure high-quality, natural hemp extracts free of synthetic additives. It distributes its products through both traditional and online retail channels.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Cosma Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cosma Spolka Akcyjna

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cosma Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Kodiak Sciences Inc. Logo
Developing durable biologics to treat high-prevalence retinal diseases and prevent blindness.
United States of America
KOD
Kohjin Bio Co., Ltd. Logo
A CDMO providing culture media & bioservices for cell therapy, research, and diagnostics.
Japan
177A
KOLON LIFE SCIENCE Inc. Logo
Develops gene therapies and manufactures APIs, providing global CDMO/CMO services.
South Korea
102940
Kolon TissueGene, Inc. Logo
Developing cell and gene therapies for orthopedic and degenerative disorders.
United States of America
950160
Develops animal health products and novel drugs for human cancer and autoimmune diseases.
South Korea
041960
KOREA ARLICO PHARM CO.,LTD. Logo
Manufactures generic drugs and provides CDMO services to a global market.
South Korea
260660
Develops and manufactures prescription (ETC) and over-the-counter (OTC) medicines for public health.
South Korea
014570
South Korea
032300
KOREA UNITED PHARM INC Logo
South Korea
033270
Korro Bio, Inc. Logo
A clinical-stage biopharma using RNA editing to develop medicines for rare & prevalent diseases.
United States of America
KRRO

Talk to a Data Expert

Have a question? We'll get back to you promptly.